Antibody-drug conjugates combined with immunotherapy have redefined the standard of care for advanced bladder cancer, ...

Dr. Petros Grivas discusses the importance of tailoring treatment decisions in bladder cancer based on data from three ...

Urothelium is the term for the mucous membrane that lines the urinary tract. This includes the renal pelvis, ureter, urinary ...

Up to 40% of patients with bladder cancer have renal impairment ... This article will discuss therapeutic strategies for patients with advanced TCC and renal impairment. It should be stressed ...

A DAILY pill for the most common form of bladder cancer has been given the green light for NHS use. Erdafitinib, which blocks ...

Advanced transitional-cell carcinoma of the bladder is the most common cancer of the urinary tract, with a high mortality rate. Cisplatin-based chemotherapy has demonstrated prolonged survival of ...

Patients with advanced (muscle-invasive) bladder cancer had significantly less risk of the cancer progressing or returning when treated with durvalumab, and were more likely to still be alive two ...

Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration ...

A supplemental biologics license application has been submitted to the FDA for nogapendekin alfa plus Bacillus ...

New bladder cancer treatment rolled out by NHS - Hundreds will benefit after the first targeted treatment for the most common ...

Bladder cancer patients given an immunotherapy drug are a third less likely to see disease come back and are more likely to ...